The use of biologic medications for the treatment of cutaneous immune-related adverse events secondary to immune checkpoint inhibitors: A single-institution real-life study by Jade N. Young, BS, Hannah Verma, BA, Nour El Kashlan, MD, Dina Poplausky, BA, Angela J. Lamb, MD, Emma Guttman-Yassky, MD, PhD, Nicholas Gulati, MD, PhD

Connect to this object online.

Toxic epidermal necrolysis-like linear IgA bullous dermatosis as a manifestation of multiple drug hypersensitivity in the setting of drug reaction with eosinophilia and systemic sy... by Scott Stratman, MD, MPH, Lisa Zhou, MD, Randie H. Kim, MD, Robert G. Phelps, MD, Jacob Glickman, MD, Daniela Mikhaylov, MD, Jianni Wu, MD, Nour El-Kashlan, MD, Ryan Rivera-Oyola, MD, Jonas A. Adalsteinsson, MD, PhD, Melissa A. Levoska, MD, Nicholas Gulati, MD, PhD

Connect to this object online.